Annual Congress Vienna 2003

Saturday, 27.09.2003
Sunday, 28.09.2003
Monday, 29.09.2003
Tuesday, 30.09.2003
Wednesday, 01.10.2003

Citations should be made in the following way: Authors. Title. Eur Respir J 2003; 22: Suppl. 45, abstract number.

Material from 2003:

3196 Abstracts
374 Slide presentations

Material from 2003: Show

Bronchiolitis obliterans: diagnosis and treatment

Oral Presentation
Chairs: A. Boehler (Zurich, Switzerland), S. Keshavjee (Toronto, Canada)

Download all media

Comparison of differential cell counts and interleukin-8 levels in bronchoalveolar lavage and induced sputum from lung transplant recipients E. Mamessier, F. Milhe, S. boniface, P. Dupuy, D. Vervloet, P. Thomas, A. Magnan, M. Reynaud-Gaubert (Marseille, France)
IL-6 promotor polymorphism (-174 C/G) and onset of bronchiolitis obliterans syndrome after lung transplantation M. Hofer, T. Rechsteiner, E. W. Russi, A. Boehler (Zurich, Switzerland)
Effects of posttransplant bronchiolitis obliterans syndrome (BOS) on exhaled nitric oxide (eNO) A. Van Muylem, M. Estenne (Brussels, Belgium)
MMP-7 / MMP-9 in stable lung transplant recipients - a potential role in obliterative bronchiolitis I. A. Forrest, C. Ward, G. Pritchard, A. D. Rowan, T. E. Cawston, P. A. Corris (Newcastle-upon-Tyne, United Kingdom)
N-acetyl cysteine inhibits IL-17-induced IL-8 production from human airway smooth muscle cells - a possible role for anti-oxidant treatment in chronic lung rejection? W. A. Wuyts, B. M. Vanaudenaerde, L. J. Dupont, D. E. Van Raemdonck, M. G. Demedts, G. M. Verleden (Leuven, Belgium)
Hypo gammaglobulinemia (gG) after lung transplantation: impact of non specific gG replacement on infection and rejection C. Pison, C. Découchon, B. Coltey, I. Pin, C. Chevallier, O. Chavanon, C. Sessa, D. Blin (Grenoble, France)
Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx) G. M. Verleden, L. J. Dupont, M. Delcroix, D. E. Van Raemdonck (Leuven, Belgium)